现代医药卫生2024，Vol.40Issue(1)：1-9,9.DOI:10.3969/j.issn.1009-5519.2024.01.001
2022年英国风湿病学会《孕期和哺乳期用药-免疫调节抗风湿药物和皮质激素类药物》指南解读
Understanding of"Prescribing drugs in pregnancy and breastfeeding:immunomodulatory anti-rheumatic drugs and corticosteroids"guideline by the British Society of Rheumatology in 2022
摘要
Abstract
The British Society for Rheumatology(BSR)published"Prescribing drugs in pregnancy and breastfeeding:immunomodulatory anti-rheumatic drugs and corticosteroids"guideline on November 2,2022,the guideline provides the guidance suggestion on prescribing antirheumatic drugs during pregnant period and lactation period,the contents include the safety of antimalarials;corticosteroids;conventional synthetic DMARDs(csDMARDs)and immunosuppressive therapies;biologic DMARDs(bDMARDs);and targeted syn-thetic DMARDs(tsDMARDs)during pregnant period and lactation period,the recommendations for father medication,and replenish the recommendations for bMDARDs and tsDMARDs in order to provide a basis for the medical staff to use these kinds of drugs.关键词
风湿免疫病/妊娠期/哺乳期/父亲/药物/安全性Key words
Rheumatic immune/Pregnancy/Breastfeeding/Father/Drugs/Safety分类
医药卫生引用本文复制引用
姚蓉,董晓静..2022年英国风湿病学会《孕期和哺乳期用药-免疫调节抗风湿药物和皮质激素类药物》指南解读[J].现代医药卫生,2024,40(1):1-9,9.基金项目
国家儿童健康与疾病临床医学研究中心临床医学研究一般项目(NCRCCHD-2020-GP-16). （NCRCCHD-2020-GP-16）
